CHICAGO--(BUSINESS WIRE)--Chicago Mayor Rahm Emanuel and Medacta USA President Eric Dremel today announced the official opening of Medacta USA’s new headquarters in Chicago. Medacta USA is a subsidiary of Medacta® International, a privately held, family-owned global leader in the design of innovative joint replacement and spine surgery products. The 20,000 square foot facility located at 1556 West Carroll Avenue is expected to bring more than 50 jobs to the city, uniting Medacta USA’s operations, product development, sales, and marketing functions together in a city and region known for its deep medical technology roots.
“I am pleased to welcome Medacta International’s new U.S. headquarters to Chicago,” said Mayor Rahm Emanuel. “One of the main objectives of the Plan for Economic Growth and Jobs is to ensure that companies like Medacta see Chicago as the ideal location for new corporate headquarters. This is proof that our efforts to create new jobs and grow the city’s economy are working.”
Medacta USA relocated its headquarters from Southern California to better support the company’s expansion into the U.S. orthopedics market. Since receiving initial FDA regulatory clearances in 2009, Medacta USA has experienced rapid year-over-year growth, and its knee, hip, and spine products have received accolades from surgeons nationwide. The company will continue to innovate with several new product introductions this year.
“Everyone at Medacta USA is thrilled to call Chicago our new home,” said Medacta USA President Eric Dremel. “The city combines a deep technical talent pool with the opportunity to collaborate with some of the world’s best orthopedic researchers and practitioners at leading medical institutions. Chicago’s central location also makes it an excellent base from which to tap into the stream of medical technology and orthopedic innovation centered in the Midwest. We are grateful for the city’s warm welcome, and we look forward to becoming a strong contributor to its business community.”
In recent years, Chicago has grown to become a medical technology epicenter, as supported by the city’s ChicagoNEXT effort to drive growth in science, technology, innovation and entrepreneurship. As part of the Plan for Economic Growth and Jobs, Mayor Emanuel has tasked World Business Chicago with oversight of the city’s efforts to grow the region’s healthcare, biopharmaceutical, health IT, academic, and medical device communities, by supporting companies poised to make an impact on the city’s economy and the world of healthcare at large.
Medacta’s new location will allow the company to leverage the city’s resources and will put the company in the heart of an economic engine for medical technology research, development, and innovation. The health services industry in the Chicago region employs more than 525,000 people and includes 91 hospitals and 6 medical schools. “Chicago’s business-friendly environment and robust community of top medical talent make it an ideal location for companies such as Medacta to grow and prosper,” said World Business Chicago President and Chief Executive Officer Jeff Malehorn. “Attracting U.S. headquarters of international companies and supporting innovation in emerging sectors are key components of Mayor Emanuel’s Plan for Economic Growth and Jobs, and we’re pleased to welcome Medacta to our rich community of health, science, and technology institutions.”
Today’s announcement was made in conjunction with an open house event at Medacta USA’s new headquarters. The event highlighted company milestones to date as well as Medacta’s commitment to responsible innovation that benefits patients, doctors, and the healthcare system at large. Partners, advocates, clinicians, and current employees were invited to hear from key leadership and Chicago city officials on the importance of the move to Medacta’s long-term potential and the company’s newly added value to Chicago’s technology and medical ecosystem. The event drew surgeons from around the world who were in Chicago attending the first Advanced AMIS® (Anterior Minimally Invasive Surgery) Hip Course at Northwestern University and the 161st Basic AMIS Learning Center. Pioneered by Medacta and leading orthopedic surgeons, AMIS is a muscle-sparing technique for hip replacement that facilitates a shortened recovery time, fewer dislocations and improved patient satisfaction.
Medacta USA’s parent company, Medacta International, was founded in 1999 by entrepreneur Alberto Siccardi after a personal experience with joint replacement compelled him to seek solutions that improve the experience for fellow patients. Medacta International is one of the fastest growing orthopedics firms worldwide, as well as the largest European based knee and hip replacement manufacturer. Unique to Medacta is its focus on surgical training and education: the company has trained 2000 surgeons worldwide at its learning centers, while the biennial M.O.R.E. International Symposium attracts hundreds of renowned surgeons from across the world.
About World Business Chicago
World Business Chicago leads Chicago’s business retention, attraction and expansion efforts and raises the city’s position as a premier global business destination. Chaired by Mayor Rahm Emanuel, WBC fosters private sector growth through the advancement of a business-friendly environment that attracts world-class talent, and is responsible for the implementation of Chicago’s economic growth and jobs.
About Medacta USA, Inc.
A subsidiary of Medacta International, Medacta USA, Inc. is a leading manufacturer of orthopedic implants, neurosurgical systems, and instrumentation. Medacta’s revolutionary approach and responsible innovation have resulted in standard of care breakthroughs in hip replacement with the AMIS system and total knee replacement with MyKnee® patient matched technology. Over the last 10 years, Medacta has grown dramatically by taking a holistic approach and placing value on all aspects of the care experience from design to training to sustainability. Medacta USA is headquartered in Chicago, Illinois. For more information about the company, please visit www.medacta.com.
